1.02 (-%)
As of Nov 12, 2024
Source:
We are a biopharmaceutical company focused on developing gene therapies to cure blindness diseases and developing a vaccine to save lives from COVID-19.
Country | United States |
Headquarters | malvern, pennsylvania |
Phone Number | 484-328-4701 |
Industry | manufacturing |
CEO | Shankar Musunuri |
Website | ocugen.com |